CBD for Pets: New Research Validates Growing Demand, and KND Labs Is Leading the Pack
The pet wellness industry is in the midst of a major evolution. With consumers increasingly prioritizing holistic care for their animals, CBD has emerged as a trusted ingredient in addressing pet anxiety, pain, inflammation, and age-related mobility issues. Now, a comprehensive new study by the APH Veterinary Cannabis Council adds data to what many in the industry already suspected: CBD is not only growing in popularity among pet owners, but it is also being increasingly embraced by veterinarians.
These findings underscore a critical opportunity for pet wellness brands. But they also highlight a risk: as more companies rush to meet demand, not all CBD ingredients are created equal. For brands looking to grow in this category, the supplier they choose can either reinforce or jeopardize their credibility.
Key Findings from the 2025 Pet CBD Study
A new 2025 report from the APH Veterinary Cannabis Council offers one of the most comprehensive looks yet at CBD usage in companion animals. The findings confirm what many brands have long believed: demand is high, usage is growing, and veterinary acceptance is catching up.
Highlights include:
-
71% of pet owners report having used CBD for their dogs or cats.
-
The leading reasons for use were anxiety relief, joint/mobility support, and general wellness.
-
91% of veterinarians surveyed said clients have asked them about CBD in the past year.
-
78% of vets rated CBD as moderately to highly effective for mobility issues.
-
Side effects were rare and mild, most often tied to incorrect dosage rather than product quality.
-
Preferred product types: tinctures (42%), chews (31%), and water-soluble drops (19%).
-
92% of veterinary professionals prefer CBD products manufactured in NASC-compliant or GMP-certified facilities.
This data not only validates the pet CBD category, but it also highlights the need for rigor in formulation, sourcing, and documentation.

The Role of Trust and Compliance in Pet CBD
CBD products for companion animals fall under heightened scrutiny. Consumers are sensitive to anything involving their pets’ health, and the regulatory environment remains complex. Veterinarians and retailers alike require clear documentation, NASC compliance, and assurance that every batch is safe and traceable.
KND Labs is uniquely positioned to meet this demand. As the largest CBD supplier to the pet wellness industry and a multi-year Supplier of the Year with the National Animal Supplement Council (NASC), KND Labs provides more than just ingredients. They offer a manufacturing partnership grounded in transparency, documentation, and regulatory readiness.
Every ingredient is supported by:
-
Full Certificates of Analysis (COAs)
-
Batch-level third-party testing
-
Safety Data Sheets (SDS)
-
Chain-of-custody documentation
-
NASC-compliant production standards
This level of rigor ensures pet brands meet the highest safety and quality standards demanded by consumers, retailers, and veterinary professionals alike.
From Concept to Launch: Pet Product Development with KND Labs
For brands developing new pet products, working with KND Labs means eliminating guesswork and reducing time to market. KND's white label and private label capabilities include a range of pet-focused delivery formats, such as tinctures, chews, and water-soluble options. These products are built using human-grade manufacturing standards in cGMP and ISO 9001:2015-certified facilities, offering both quality and speed.
Popular turnkey product formats include:
-
Broad-spectrum or isolate-based tinctures
-
Soft chews for stress or mobility support
-
Apex Water Soluble™ CBD formulations
-
Mushroom-cannabinoid blends for immune and cognitive support, including ClearIQ™ from MycoTechnology
-
Custom formulations with functional ingredients like turmeric or L-theanine
Many brands entering the pet wellness space underestimate the complexity involved in cannabinoid formulation. From ensuring accurate dosing for various animal sizes to understanding ingredient interactions with common pet supplements, the margin for error is small—and the cost of a misstep can be high.
KND’s process mitigates that risk by offering built-in regulatory oversight, ongoing batch consistency, and a team that understands not just cannabinoids, but how they work in real-world pet formulations. This reduces the friction of trial-and-error development and helps your team move confidently from R&D into commercialization.
Why This Study Matters for Pet Wellness Brands
This latest research isn’t just validation of consumer trends; it provides the data-driven confidence that pet wellness brands and veterinarians have been waiting for. Critically, it also confirms the need for brands to prioritize quality, regulatory readiness, and trust-building at every step of product development.
Pet wellness brands cannot afford to cut corners on ingredient integrity, documentation, or compliance. Formulating with a trusted, NASC-compliant supplier like KND Labs ensures your products are built on a foundation of safety, consistency, and scientific rigor.
The Opportunity Ahead
CBD is now a central part of the pet wellness conversation. Brands that want to lead in this category must move beyond commodity sourcing and treat ingredient partnerships as strategic assets. With consumer expectations rising and regulatory scrutiny increasing, the question is no longer “Should we launch a pet CBD product?” but rather, “How can we do it right?”
Here’s what doing it right looks like with KND Labs:
-
Scalable manufacturing capacity from 1 kg to 1,000+ kg per month
-
In-house formulation expertise tailored to pet wellness
-
Flexible private label and white label options
-
Technical support from compliance to commercialization
-
Global fulfillment readiness, including EU/UK documentation
Whether you're expanding an existing product line or launching your first pet wellness SKU, KND provides the compliance-ready infrastructure, formulation support, and manufacturing scale to bring your vision to life.
Final Thoughts
The 2025 APH study reflects what many pet brands already feel on the ground: consumers trust CBD, and veterinarians are catching up. But trust in the ingredient must be matched by trust in the supplier.
The brands that will define the next generation of pet wellness are those willing to invest in quality, documentation, and trust. With its NASC recognition, ingredient consistency, and a deep bench of technical expertise, KND Labs offers more than just manufacturing capacity—it offers partnership.
So whether you’re entering the CBD category for the first time or optimizing a full product suite, there’s one name pet brands trust to deliver with precision: KND Labs.
Ready to create a pet wellness product that sets a new standard?
Contact KND Labs to schedule your formulation consultation today.